Autologous Bone Marrow Mononuclear Cell Transplantation
Autologous Bone Marrow Mononuclear Cell Transplantation is a medical procedure with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
12.5%
1 of 8 finished
87.5%
7 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial Hemorrhage
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida
Stem Cell Therapy in Limb Girdle Muscular Dystrophy
Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury
Stem Cell Therapy in Autism Spectrum Disorders
Clinical Trials (10)
Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial Hemorrhage
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina Bifida
Stem Cell Therapy in Limb Girdle Muscular Dystrophy
Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury
Stem Cell Therapy in Autism Spectrum Disorders
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke
Stem Cell Therapy in Spinal Cord Injury
Stem Cell Therapy in Traumatic Brain Injury
Stem Cell Therapy for Cerebral Palsy
Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients
All 10 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 10